Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fei Mao, Jianheng Li, Hui Wei, Ling Huang & Xingshu Li. (2015) Tacrine–propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry 30:6, pages 995-1001.
Read now
Read now
Articles from other publishers (30)
Sushil K. Jain, Christopher M. StevensJeffrey Justin MargretSteven N. Levine. (2023)
Alzheimer's Disease: A Review of Pathology, Current Treatments, and the Potential Therapeutic Effect of Decreasing Oxidative Stress by Combined Vitamin D and
l
-Cysteine Supplementation
. Antioxidants & Redox Signaling.
Crossref
Crossref
Amy C. Ogilvie & Jordan L. Schultz. (2023)
Memantine Use and Cognitive Decline in Huntington's Disease: An
Enroll‐HD
Study
. Movement Disorders Clinical Practice 10:7, pages 1120-1125.
Crossref
Crossref
Pratibha Sharma & Manjinder Singh. (2023) An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects. Life Sciences 320, pages 121568.
Crossref
Crossref
Yancy Ferrer-Acosta, Sergio Rodriguez-Massó, Dinely Pérez, Vesna A. Eterovic, P.A. Ferchmin & Antonio Henrique Martins. (2022) Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult. Toxicology in Vitro 84, pages 105453.
Crossref
Crossref
Carlen A. Yuen, Jing-Mei Hsu, Koen Van Besien, Ran Reshef, Fabio M. Iwamoto, Aya Haggiagi, Benjamin Liechty, Cenai Zhang, Sarah F. Wesley & Rajiv Magge. (2022) Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience. Journal of Immunotherapy 45:5, pages 254-262.
Crossref
Crossref
Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez & Lucía Melguizo-Rodríguez. (2022) Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 14:6, pages 1117.
Crossref
Crossref
Nikita Subhash Hinge, Himanshu Kathuria & Murali Monohar Pandey. (2022) Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Applied Materials Today 26, pages 101303.
Crossref
Crossref
Yi XiaoTie-Song ZhangYing-Hua LiChen-Fei LiuShao-Jie Yang, Li-Ting ZengSheng-He HuangXiao-Yan DengLiang Peng. (2022)
Memantine Promotes Bactericidal Effect of Neutrophils Against Infection with
Pseudomonas aeruginosa
and Its Drug-Resistant Strain, by Improving Reactive Oxygen Species Generation
. Microbial Drug Resistance 28:1, pages 7-17.
Crossref
Crossref
Agnieszka Jankowska, Maciej Pawłowski & Grażyna Chłoń-Rzepa. (2021) Diabetic Theory in Anti-Alzheimer’s Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors. Current Medicinal Chemistry 28:18, pages 3535-3553.
Crossref
Crossref
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, Ghulam Md Ashraf, May N. Bin-Jumah & Mohamed M. Abdel-Daim. (2020) Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets. Molecular Neurobiology 58:1, pages 281-303.
Crossref
Crossref
Yanyue Wu, Zhiguo Lu, Yan Li, Jun Yang & Xin Zhang. (2020) Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection. Nanomaterials 10:8, pages 1441.
Crossref
Crossref
Angela Georgia Catic. 2020. Dementia and Chronic Disease. Dementia and Chronic Disease
23
37
.
Rosa Purgatorio, Modesto de Candia, Annalisa De Palma, Francesco De Santis, Leonardo Pisani, Francesco Campagna, Saverio Cellamare, Cosimo Altomare & Marco Catto. (2018) Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity. Molecules 23:7, pages 1544.
Crossref
Crossref
Yi-xiang Xu, Huan Wang, Xiao-kang Li, Sheng-nan Dong, Wen-wen Liu, Qi Gong, Tian-duan-yi Wang, Yun Tang, Jin Zhu, Jian Li, Hai-yan Zhang & Fei Mao. (2018) Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 143, pages 33-47.
Crossref
Crossref
Xiaokang Li, Huan Wang, Yixiang Xu, Wenwen Liu, Qi Gong, Wei Wang, Xiaoxia Qiu, Jin Zhu, Fei Mao, Haiyan Zhang & Jian Li. (2017) Novel Vilazodone–Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation. ACS Chemical Neuroscience 8:12, pages 2708-2721.
Crossref
Crossref
Leonardo Pisani, Annalisa De Palma, Nicola Giangregorio, Daniela V. Miniero, Paolo Pesce, Orazio Nicolotti, Francesco Campagna, Cosimo D. Altomare & Marco Catto. (2017) Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone: A water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity. European Journal of Pharmaceutical Sciences 109, pages 381-388.
Crossref
Crossref
Tarek Mohamed, Mandeep K. Mann & Praveen P. N. Rao. (2017) Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease. RSC Advances 7:36, pages 22360-22368.
Crossref
Crossref
Xiaokang Li, Huan Wang, Zhengyu Lu, Xinyu Zheng, Wei Ni, Jin Zhu, Yan Fu, Fulin Lian, Naixia Zhang, Jian Li, Haiyan Zhang & Fei Mao. (2016) Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents. Journal of Medicinal Chemistry 59:18, pages 8326-8344.
Crossref
Crossref
Christophe Genicot & Laurent Provins. 2016. Lead Generation. Lead Generation
513
546
.
Roberta Farina, Leonardo Pisani, Marco Catto, Orazio Nicolotti, Domenico Gadaleta, Nunzio Denora, Ramon Soto-Otero, Estefania Mendez-Alvarez, Carolina S. Passos, Giovanni Muncipinto, Cosimo D. Altomare, Alessandra Nurisso, Pierre-Alain Carrupt & Angelo Carotti. (2015)
Structure-Based Design and Optimization of Multitarget-Directed 2
H
-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases
. Journal of Medicinal Chemistry 58:14, pages 5561-5578.
Crossref
Crossref
M.Y. Liu, S. Wang, W.F. Yao, Z.J. Zhang, X. Zhong, L. Sha, M. He, Z.H. Zheng & M.J. Wei. (2014) Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice. Neuroscience 273, pages 141-151.
Crossref
Crossref
Jan Korabecny, Rafael Dolezal, Pavla Cabelova, Anna Horova, Eva Hruba, Jan Ricny, Lukas Sedlacek, Eugenie Nepovimova, Katarina Spilovska, Martin Andrs, Kamil Musilek, Veronika Opletalova, Vendula Sepsova, Daniela Ripova & Kamil Kuca. (2014) 7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. European Journal of Medicinal Chemistry 82, pages 426-438.
Crossref
Crossref
Guilherme Monteiro Gomes, Gerusa Duarte Dalmolin, Julia Bär, Anna Karpova, Carlos Fernando Mello, Michael R. Kreutz & Maribel Antonello Rubin. (2014) Inhibition of the Polyamine System Counteracts β-Amyloid Peptide-Induced Memory Impairment in Mice: Involvement of Extrasynaptic NMDA Receptors. PLoS ONE 9:6, pages e99184.
Crossref
Crossref
Fei Mao, Jianwen Chen, Qi Zhou, Zonghua Luo, Ling Huang & Xingshu Li. (2013) Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity. Bioorganic & Medicinal Chemistry Letters 23:24, pages 6737-6742.
Crossref
Crossref
Kamalpreet Kour, Rupinder Kaur & Jasvinder Singh. (2013) Memantine for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Hans J. Leis & Werner Windischhofer. (2012) Quantitative determination of memantine in human plasma by GC using negative ion chemical ionization MS detection after derivatization with a new reagent, o-(pentafluorobenzyloxycarbonyl)-2,3,4,5-tetrafluorobenzoyl chloride. Microchimica Acta 179:3-4, pages 249-255.
Crossref
Crossref
Hans J. Leis & Werner Windischhofer. (2012) Determination of memantine in human plasma by GC using negative ion chemical ionization MS detection after derivatization with a new reagent. Microchimica Acta 178:3-4, pages 309-314.
Crossref
Crossref
M. Rushaidhi, N.D. Collie, H. Zhang & P. Liu. (2012) Agmatine selectively improves behavioural function in aged male Sprague–Dawley rats. Neuroscience 218, pages 206-215.
Crossref
Crossref
R Boada, C Hutaff-Lee, A Schrader, D Weitzenkamp, T A Benke, E J Goldson & A C S Costa. (2012) Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial. Translational Psychiatry 2:7, pages e141-e141.
Crossref
Crossref
Daniel C. Mathews, Ioline D. Henter & Carlos A. ZarateJrJr. (2012) Targeting the Glutamatergic System to Treat Major Depressive Disorder. Drugs 72:10, pages 1313-1333.
Crossref
Crossref